1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBreast and Cervical Cancer Screening Program is sponsored by State of Rhode Island. Cancer Registry <a href="/laboratory-testing/chemical-threats-preparedness-and-resp
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Breast and Cervical Cancer Screening Program | Department of Health Breast and Cervical Cancer Screening Program To reduce the number of cases and deaths due to breast and cervical cancer, among those with limited access to healthcare.
Health Insurance status, uninsured - having no health insurance; OR underinsured - having health insurance but the co-pay, deductible or out of pocket expense associated with the breast/cervical screening/follow-up care is unaffordable and has created a barrier to care Income level - less than 250% of Federal Poverty Level Click here to view the income levels Residency - must be a Rhode Island resident Provide screening and diagnostic services to eligible individuals in various age groups: Click here to view the eligible age guidelines for screenings.
Cervical cancer screening (Pap test alone every three years); Breast cancer screening (clinical breast exam, only if performed in conjunction with Pap test); Diagnostic services and follow-up, if an abnormality is found in a screening test.
Cervical cancer screening (Pap test alone every three years, OR high-risk HPV test alone every 5 years, OR Pap and high-risk HPV test together every 5 years); Breast cancer screening (clinical breast exam, only if performed in conjunction with Pap test); Diagnostic services and follow-up, if an abnormality is found in a screening test.
Cervical cancer screening (Pap test alone every three years, OR high-risk HPV test alone every 5 years, OR Pap and high-risk HPV test together every 5 years); Breast cancer screening (mammogram and clinical breast exam every year); Diagnostic services and follow-up, if an abnormality is found in a screening test. Not eligible for program services.
Exception: Individuals without Medicare Part B and undocumented residents are eligible for all program services. People with symptoms suspicious for breast cancer, OR, and abnormal finding on a clinical breast exam are eligible for breast services including diagnostic follow-up.
Individuals at high-risk for breast cancer People who are determined to be at high-risk for breast cancer can be screened with both an annual mammogram and an annual breast MRI.
Refer to treatment if needed As an extension of the Breast and Cervical Cancer Screening program, a person who is uninsured may apply for Medical Assistance (Medicaid) through the program to cover the cost of treatment for a precancerous condition of the breast/cervix or a diagnosis of breast of cervical cancer.
In order to qualify for Medical Assistance through this program, an individual must: Meet the eligibility requirements of enrollment into the Breast and Cervical Cancer Screening Program AND Be a US citizen (and show proof - U.S. Passport or U.S. Birth Certificate) or be a qualified immigrant for a minimum of five years (must provide copy of a permanent resident alien card).
Please note: a working VISA or a copy of a social security card is not considered proof of permanent resident alien status; and Show proof of Rhode Island residency (driver's license, utility bill, etc.); and Have no other individual or group insurance. Please note: People age 65 and older are not eligible for Medical Assistance through the Breast and Cervical Cancer Screening Program.
Find a Breast & Cervical Cancer Screening Provider Breast cancer is one of the most commonly diagnosed cancers in Rhode Island, accounting for approximately 13% of new cancer cases annually and 7% of cancer deaths . When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus.
Breast and Cervical Cancer Screening Program Information for Healthcare Professionals The Rhode Island Breast and Cervical Cancer Screening Program provides no-cost pelvic exams, Pap tests, HPV tests, clinical breast exams, and mammograms (breast x-rays) to eligible Rhode Islanders. The program also covers many diagnostic tests.
Chronic Disease Prevention & Management, Center for Guidance, Recommendations Age Eligibility Guidelines Family Size and Income Levels Eligibility Guidelines Cervical Cancer Data Brief Reimbursement Schedule for Breast & Cervical Cancer Screening Reimbursement Schedule for Breast and Cervical Cancer Screening - Prior Period
According to the current listing, eligibility includes: See the Rhode Island grants portal for complete eligibility requirements. Confirm the full requirements in the official notice before applying.
Breast and Cervical Cancer Screening Program is funded by State of Rhode Island. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Rhode Island. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The EuroHPC Joint Undertaking launched its AI Gigafactories call on 30 July 2026 as a joint procurement, not a conventional research grant, and that distinction shapes who should respond. It seeks consortia or Special Purpose Vehicles bringing together companies, public entities, investors and other partners to establish up to seven AI Gigafactories across Europe - facilities that combine massive computing power and state-of-the-art AI processors with the software and cloud technology stacks, high-bandwidth connectivity and energy-efficient data centres needed to deliver frontier AI training, fine-tuning and inference at scale. This is the tier above the 19 AI Factories and 13 AI Factory Antennas EuroHPC already oversees, which serve SMEs and startups with free customised support; the Gigafactories are aimed at frontier-scale sovereign capacity. The financing model is blended: EuroHPC expects total private investment of more than EUR 20,000,000,000 across the EU, with successful projects receiving varying levels of EU and national co-funding calibrated to the size and range of sovereign services offered. Per-facility EU contributions have deliberately not been published, so applicants must build their own capital stack and negotiate co-funding rather than apply against a fixed grant envelope. Facilities may be established in a single Member State or span several, and cross-border developments are explicitly welcomed. The reference is EUROHPC-2026-CEI-AIGF-01 and the deadline is 12 November 2026 at 16:00 CET. Realistically this is a call for infrastructure-grade consortia with credible access to billions in capital, energy siting and hyperscale operations experience - not for individual research groups or early-stage startups, who should instead route through the existing AI Factories network.
HMGCC Co-Creation and Dstl are seeking an edge device that processes video and audio from off-the-shelf smart glasses and stitches frames into high-fidelity 3D maps for reconnaissance. The minimum deliverable is a TRL 4 proof of concept. AI, computer vision and machine learning are listed technology themes, for example algorithms that compensate for head movement while stitching frames. Essential requirements are a report on where smart-glasses data flows and who can access it, good daytime urban imagery, and a camera-based 3D map. Desirable features include low-light imaging, audio fusion, testing across several manufacturers and a three-year manufacturer roadmap, and the stretch goal is fusing audio and visual data to handle reflections and solid walls. Redesigning or physically modifying the glasses is out of scope, and data handling must comply with GDPR and manufacturer terms. The total budget is up to £60,000, about US$80,000, excluding VAT, with on average two providers funded for a 12-week project. Questions are due 29 October, pitch day is 25 November, and kick-off is targeted for January 2027. Applications close on 12 November 2026 at 17:00 UK time.
HMGCC Co-Creation and Dstl are seeking proof-of-concept small robots that can move through confined built environments across at least two of water, land and air, at TRL 4 or above. Essential requirements are a payload of at least 100 g, a demonstration in a representative built-environment scenario, and a final report with a development roadmap. Desirable features include operation in all three domains, up to one hour of operation, autonomous navigation, operation with intermittent GNSS, travel through ducts or pipes, a volume under 0.01 cubic metres and a mass under 1 kg. Humans must keep responsibility for operational decisions, and the system must not depend on continuous public cloud access. Funding is up to £60,000, about US$80,000, excluding VAT, and on average two providers are funded per challenge. The call opened on 12 October 2026. Applicants are notified on 23 November, pitch day is 7 December, and kick-off is targeted for January 2027 for a project of about 10-12 weeks. Applications close on 12 November 2026 at 17:00 UK time.
EPA Region 1's SNEP Innovative Restoration Grants (EPA-I-R1-SNEP-2026A) offer $5,312,813 across up to 8 awards of $250,000 to $1,000,000, with a 15% non-federal match, one application per organization, a 12-page narrative, and a December 11, 2026 deadline. Funding comes from the Infrastructure Investment and Jobs Act. Eligibility is limited to Rhode Island and southeastern Massachusetts.
Read articleCMS distributed $10 billion in first-year Rural Health Transformation funds to all 50 states — but per-capita disparities expose a formula that may shortchange the communities that need it most.
Read article